We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Pulse Oximetry_Performance Testing- PCBA-1 (Printed Circuit Board Assembly)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01747460
Recruitment Status : Completed
First Posted : December 11, 2012
Last Update Posted : December 6, 2013
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
To determine accuracy specifications of the Pulse oximeter.

Condition or disease
Healthy

Study Design

Study Type : Observational
Actual Enrollment : 25 participants
Time Perspective: Prospective
Official Title: Controlled Acute Hypoxia Studies Using a Bedside Respiratory Patient Monitoring System With the Functional Patient Monitoring PCBA-1
Study Start Date : September 2012
Primary Completion Date : December 2012
Study Completion Date : December 2012
Groups and Cohorts


Outcome Measures

Primary Outcome Measures :
  1. SpO2 Accuracy (percentage of blood oxygen saturation) [ Time Frame: Duration of subject visit- approx. 1.5 hours ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Healthy Subjects
Criteria

Inclusion Criteria:

  1. Male or female subjects between the ages of 18 to 50 years (inclusive).
  2. Must undergo a physical examination by a licensed physician, advanced practice nurse or physician assistant, including a 12 lead ECG, a medical history, and a blood test checking complete blood count and screening for sickle cell trait or disease
  3. All female volunteers must have a negative urine pregnancy test prior to participation.

Exclusion Criteria:

  1. Pregnancy or lactating women
  2. Unexplained syncopal episodes
  3. Hypertension (defined as a systolic pressure of >145 mmHg or a diastolic pressure >90 mm Hg on three consecutive readings)
  4. Premature ventricular contractions (PVC's) that are symptomatic or occur at a rate of more than 5/minute
  5. History of seizures (except childhood febrile seizures) or epilepsy
  6. Routine use of tranquilizers and/or excessive anxiety
  7. History of frequent headaches or migraines
  8. History of stroke
  9. Previous injury or trauma to fingers or hands that may change blood flow or vascular supply and affect our ability to test multiple sensors
  10. History of "altitude sickness" defined as headaches, malaise or dizziness when in the mountains or in an aircraft at altitude significantly above sea level for a prolonged period of time (> 1 hour)
  11. History of significant respiratory disease, such as severe asthma, emphysema, etc.
  12. Sickle cell disease or trait.
  13. The use of medications, pre-existing medical conditions, treatment for a medical condition or any other reason deemed relevant by the clinician conducting the study.
  14. Abnormal ECG finding
  15. Prior or known allergies to lidocaine (or similar pharmacologic agents, e.g., Novocain)
  16. Prior or known allergies to heparin.
  17. History of transient ischemic attacks or carotid artery disease
  18. History of myocardial ischemia, angina, myocardial infarction, congestive heart failure or cardiomyopathy
  19. History of chronic renal impairment
  20. History of recent arterial cannulation (less than 1 month prior to study)
  21. History of complications from previous arterial cannulation
  22. Current use of blood thinners
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01747460


Locations
United States, Colorado
Covidien
Boulder, Colorado, United States, 80301
Sponsors and Collaborators
Medtronic - MITG
More Information

Responsible Party: Medtronic - MITG
ClinicalTrials.gov Identifier: NCT01747460     History of Changes
Other Study ID Numbers: COVMOPR0250
First Posted: December 11, 2012    Key Record Dates
Last Update Posted: December 6, 2013
Last Verified: December 2013

Keywords provided by Medtronic - MITG:
Subjects